SCHEMBL30494036

SCHEMBL30494036

CN1CCN(c2ccc(NC3=N/C(=C\c4ccc5ncn(C)c5c4)C(=O)N3)cc2)CC1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK2 Q92630 18/20 0.71
▸ DYRK1A Q13627 17/20 0.71
▸ DYRK1B Q9Y463 17/20 0.71
▸ DYRK3 O43781 16/20 0.71
▸ CLK1 P49759 10/20 0.71
▸ CLK4 Q9HAZ1 10/20 0.71
▸ CLK2 P49760 9/20 0.71
▸ CLK3 P49761 8/20 0.71
▸ GSK3B P49841 7/20 0.71
▸ DYRK4 Q9NR20 5/20 0.71
▸ CSNK1E P49674 1/20 0.71
▸ PIM1 P11309 9/20 0.67
▸ CSNK2A2 P19784 5/20 0.67
▸ CSNK2B P67870 5/20 0.67
▸ CSNK2A1 P68400 5/20 0.67
▸ CSNK2A3 Q8NEV1 5/20 0.67
▸ CNR1 P21554 2/20 0.54
▸ PIM3 Q86V86 1/20 0.54
▸ PIM2 Q9P1W9 1/20 0.54
▸ CDK5 Q00535 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26093920 1.00 DYRK2 (0.71) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL30363298 0.86 DYRK1A (0.75) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL26093954 0.86 DYRK1A (0.75) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL23499919 0.85 DYRK1A (0.62) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL28842956 0.85 DYRK1A (0.62) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL29899892 0.85 DYRK1A (0.62) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL23970091 0.83 DYRK1A (1.00) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL26095402 0.83 DYRK2 (0.70) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL30494100 0.83 DYRK2 (0.49) DYRK2DYRK1ADYRK1BDYRK3CLK1
SCHEMBL26096370 0.83 DYRK2 (0.49) DYRK2DYRK1ADYRK1BDYRK3CLK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP claimed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO claimed
EP-4422753-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 Perha Pharmaceuticals (FR) 2024-09-04 — — EP disclosed
WO-2023072966-A1 IMIDAZOLONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES IN PARTICULAR DYRK1A, CLK1 AND/OR CLK4 PERHA PHARMACEUTICALS (FR) 2023-05-04 — — WO disclosed
Send feedback